Needham Reiterates Buy Rating on Accolade Inc. (ACCD)

Go back to Needham Reiterates Buy Rating on Accolade Inc. (ACCD)

Accolade Inc. (ACCD) PT Lowered to $7.50 at Truist Securities

October 9, 2024 5:57 AM UTC

Truist Securities analyst Jailendra Singh lowered the price target on Accolade Inc. (NASDAQ: ACCD) to $7.50 (from $9.00) while maintaining a Buy rating.

The analyst comments "We had a post-quarterly call with ACCD management to discuss 2FQ25 results, its FY25 expectations, views on the... More

Accolade Inc. (ACCD) PT Lowered to $5.75 at BofA Securities

October 8, 2024 3:38 PM UTC

BofA Securities analyst Michael Cherny lowered the price target on Accolade Inc. (NASDAQ: ACCD) to $5.75 (from $7.00) while maintaining a Buy rating.

The analyst comments "Accolades 2Q results largely reiterated ongoing themes in the business improving profitability as revenue growth moderates. The current... More

Piper Sandler Reiterates Overweight Rating on Accolade Inc. (ACCD)

October 8, 2024 12:10 PM UTC

Piper Sandler analyst Jessica Tassan reiterated an Overweight rating and $9.00 price target on Accolade Inc. (NASDAQ: ACCD).

The analyst comments "We reiterate our Overweight rating, $9 PT on ACCD following a solid F2Q25 print where revenue and adjusted EBITDA exceeded PSC/... More

Truist Securities Reiterates Buy Rating on Accolade Inc. (ACCD)

October 8, 2024 10:15 AM UTC

Truist Securities analyst Jailendra Singh reiterated a Buy rating and $9.00 price target on Accolade Inc. (NASDAQ: ACCD)

The analyst comments "Bottom Line. ACCD reported strong FY2Q25 results, with both revenue and adjusted EBITDA coming in above guidance and consensus expectations.... More

BTIG Reiterates Neutral Rating on Accolade Inc. (ACCD)

October 8, 2024 9:41 AM UTC

BTIG analyst David Larsen reiterated a Neutral rating on Accolade Inc. (NASDAQ: ACCD).

The analyst comments "On Tuesday, 10/8/24 BMO, ACCD reported good F2Q:25 results, with an EBITDA and revenue beat, relative to consensus in F2Q:25. Given that ACCD re-affirmed F2025... More

Barclays Reiterates Equalweight Rating on Accolade Inc. (ACCD)

October 8, 2024 8:07 AM UTC

Barclays analyst Stephanie Davis reiterated an Equalweight rating and $5.50 price target on Accolade Inc. (NASDAQ: ACCD).

The analyst comments "Headline beat offset by 3Q guidance miss/steeper implied 4Q ramp. ACCD posted a mixed print that featured a headline beat (revs/EBITDA beat by $1M/$6M) offset by a 3Q guidance miss (revs/EBITDA missed by $5M/$4M), implying a steeper 4Q ramp vs. history given reiterated FY25 guidance. We think the EBITDA beat was likely driven by early recognition of performance guarantee (PG) revs given gross profit... More